Sunday Observer Online
  Ad Space Available Here  

Home

Sunday, 12 May 2013

Untitled-1

observer
 ONLINE


OTHER PUBLICATIONS


OTHER LINKS

Marriage Proposals
Classified
Government Gazette

GSK launches antihistamine

GlaxoSmithKline Pharmaceuticals (GSK) launched a non-sedative antihistamine syrup Histaban (loratadine), a prescription medication for allergic conditions. The syrup intended for paediatric use, is manufactured at the Glaxo Wellcome Ceylon plant in Sri Lanka.

“Loratadine is a second-generation antihistamine, and the availability of a locally developed product from GSK will be welcomed by the medical fraternity,” said Managing Director, GSK Pharmaceuticals in Sri Lanka, Stuart Chapman. “GSK's highest global standards have been adhered to in the manufacture, to ensure quality, safety and efficacy.”

“Histaban is a long-acting antihistamine and there is no restriction in a patient's activities since it is non-sedative,” a spokesman for the company said.

 

EMAIL |   PRINTABLE VIEW | FEEDBACK

ANCL TENDER NOTICE - BOOK BINDING MACHINE
TENDER NOTICE - WEB OFFSET NEWSPRINT - ANCL
www.defence.lk
Donate Now | defence.lk
www.apiwenuwenapi.co.uk
LANKAPUVATH - National News Agency of Sri Lanka
Telecommunications Regulatory Commission of Sri Lanka (TRCSL)
www.army.lk
www.news.lk
 

| News | Editorial | Finance | Features | Political | Security | Sports | Spectrum | Montage | Impact | World | Obituaries | Junior | Youth |

 
 

Produced by Lake House Copyright © 2013 The Associated Newspapers of Ceylon Ltd.

Comments and suggestions to : Web Editor